Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A retrospective cohort study to determine association of receipt of Pfizer-BNT162b2 mRNA or Moderna mRNA-1273 vaccines in patients with cirrhosis compared at risk of infection and severe disease from COVID-19

Next Previous
X
Search
Trial Profile

A retrospective cohort study to determine association of receipt of Pfizer-BNT162b2 mRNA or Moderna mRNA-1273 vaccines in patients with cirrhosis compared at risk of infection and severe disease from COVID-19

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 20 Jan 2022

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ad26.COV2 S (Primary) ; Elasomeran (Primary) ; Tozinameran (Primary)
  • Indications COVID-19 respiratory infection
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms VOCAL cohort

    • Most Recent Events

    • 12 Jan 2022 Results published in the Hepatology
    • 15 Nov 2021 Results investigating the association of receipt of the Pfizer BNT162b2 mRNA or Moderna 1273 mRNA vaccines in patients with cirrhosis compared to a propensity-matched control group of patients at similar risk of infection and severe disease from COVID-19, presented at The Liver Meeting 2021: 72nd Annual Meeting of the American Association for the Study of Liver Diseases
    • 15 Nov 2021 Results of (n=3242 unvaccinated )and (n=254 vaccinated) patients with cirrhosis, presented at The Liver Meeting 2021: 72nd Annual Meeting of the American Association for the Study of Liver Diseases

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top